Penam derivatives
    1.
    发明授权
    Penam derivatives 失效
    Penam衍生物

    公开(公告)号:US4820701A

    公开(公告)日:1989-04-11

    申请号:US112103

    申请日:1987-10-21

    CPC分类号: C07D499/00

    摘要: Antibacterial agents have the formula (I) or are pharmaceutically acceptable salts or in vivo hydrolysable esters thereof: ##STR1## wherein R.sup.3 is phenyl, substituted phenyl, cyclohexenyl, cyclohexadienyl or an optionally substituted 5- or 6-membered heterocyclic ring containing up to three hetero atoms selected from oxygen, sulphur or nitrogen, R.sup.4 is hydrogen or formamido, R.sup.5 is hydrogen, C.sub.1-6 alkyl, substituted alkyl, aryl or aralkyl, R.sup.6 and R.sup.7 are the same or different and represent hydrogen, C.sub.1-6 alkyl, substituted alkyl, halogen, amino, phenyl, substituted phenyl, hydroxyl or C.sub.1-6 alkoxy or R.sup.6 and R.sup.7 form the residue of an optionally substituted 5- or 6-membered carbocyclic ring or a 5- or 6- membered heterocyclic ring containing up to three hetero atoms selected from oxygen, sulphr or nitrogen, and X represents ##STR2## or tautomers thereof wherein R.sup.8 and R.sup.9 are the same or different and each represents hydroxy, or protected hydroxy.

    Novel intermediates for .beta.-lactams
    2.
    发明授权
    Novel intermediates for .beta.-lactams 失效
    β-内酰胺的新型中间体

    公开(公告)号:US4245089A

    公开(公告)日:1981-01-13

    申请号:US6435

    申请日:1979-01-25

    CPC分类号: C07D265/02

    摘要: Compounds of the formula (III): ##STR1## wherein R.sub.1 is alkyl of up to 3 carbon atoms and R.sub.2 is alkyl of up to 3 carbon atoms optionally joined to R.sub.1 so that R.sub.1 and R.sub.2 and the carbon atom to which they are attached form a spiro-cyclopentyl or spiro-cyclohexyl ring, and wherein the configuration about the .beta.-lactam ring is trans, are useful in the preparation of antibacterial .beta.-lactam compounds.A process for the preparation of the compounds of the formula (III), is also desired.

    摘要翻译: 式(III)的化合物:其中R 1是至多3个碳原子的烷基,R 2是至多3个碳原子的烷基,其任选地连接到R 1上,使得R 1和R 2及它们的碳原子 连接形成螺 - 环戊基或螺环己基环,并且其中关于β-内酰胺环的构型是反式的,可用于制备抗细菌β-内酰胺化合物。 还需要制备式(III)化合物的方法。

    .beta.-Lactam antibacterial agents
    5.
    发明授权
    .beta.-Lactam antibacterial agents 失效
    β-内酰胺抗菌剂

    公开(公告)号:US4350703A

    公开(公告)日:1982-09-21

    申请号:US222282

    申请日:1981-01-05

    摘要: Compounds are described of the formula (II): ##STR1## wherein R.sub.1 is a group such that CO.sub.2 R.sub.1 is an ester group; A.sub.1 is a hydrogen atom; and A.sub.2 is a group CR.sub.2 R.sub.3 R.sub.4 wherein R.sub.2 is a hydrogen atom or a hydroxyl group; R.sub.3 is a hydrogen atom or a lower alkyl group; and R.sub.4 is a hydrogen atom or a lower alkyl group, a benzyl group, a phenyl group or is joined to R.sub.3 to form part of a C.sub.5-7 carboxylic ring or is a group of the formula CH(OH)R.sub.5 or CHX wherein R.sub.5 is a hydrogen atom or lower alkyl group and X is an oxygen atom or a CR.sub.6 R.sub.7 group where R.sub.6 is a hydrogen atom or a lower alkyl, phenyl, CN, CO.sub.2 R.sub.8 where R.sub.8 is a lower alkyl, phenyl or benzyl group and R.sub.7 is a hydrogen atom or a lower alkyl group or is joined to R.sub.6 to form part of a C.sub.5-7 carbocyclic ring. These compounds have been found to possess antibacterial properties. The preparation of these compounds is described.

    摘要翻译: 化合物描述为式(II):其中R 1是使CO 2 R 1是酯基的基团; A1是氢原子; A2为基团CR2R3R4,其中R2为氢原子或羟基; R3是氢原子或低级烷基; R4为氢原子或低级烷基,苄基,苯基或与R3结合形成C5-7羧酸环的一部分,或为式CH(OH)R5或CHX的基团,其中R5 是氢原子或低级烷基,X是氧原子或其中R6是氢原子或低级烷基,苯基,CN,CO2R8的CR6R7基团,其中R8是低级烷基,苯基或苄基,R7是氢 原子或低级烷基,或者连接到R6以形成C5-7碳环的一部分。 已经发现这些化合物具有抗菌性质。 描述了这些化合物的制备。

    Chemical process
    6.
    发明授权
    Chemical process 失效
    化学工艺

    公开(公告)号:US4521337A

    公开(公告)日:1985-06-04

    申请号:US475247

    申请日:1983-03-14

    摘要: A process for the preparation of a compound of the formulae (Ia) and/or (Ib): ##STR1## wherein R.sup.1 and R.sup.2 are independently substituted or unsubstituted hydrocarbon groups or are joined together so as to form a carbocyclic or heterocyclic ring, and R.sup.3 is a substituted or unsubstituted hydrocarbon group; which process comprises the ring-closing cyclization of a compound of the formula (II): ##STR2## wherein R.sup.1, R.sup.2 and R.sup.3 are as defined in relation to formulae (Ia) and (Ib).

    摘要翻译: 制备式(Ia)和/或(Ib)化合物的方法:其中R 1和R 2独立地是取代或未取代的烃基或连接在一起以形成碳环或杂环,以及 R3是取代或未取代的烃基; 该方法包括式(II)化合物的闭环环化:其中R 1,R 2和R 3如关于式(Ia)和(Ib)所定义)。

    .beta.-Lactam antibiotics, a process for their preparation and their use
in pharmaceutical compositions
    7.
    发明授权
    .beta.-Lactam antibiotics, a process for their preparation and their use in pharmaceutical compositions 失效
    β-内酰胺抗生素,其制备方法及其在药物组合物中的应用

    公开(公告)号:US4263314A

    公开(公告)日:1981-04-21

    申请号:US4891

    申请日:1979-01-19

    CPC分类号: C07D477/20 C07D477/04

    摘要: The present invention provides the antibacterial agents of the formula (II): ##STR1## wherein R.sub.1 is a group such that CO.sub.2 R.sub.1 is a carboxylic acid group or a salt thereof or is a group of the formula CO.sub.2 R.sub.1.sup.1 wherein R.sub.1.sup.1 is a group such that CO.sub.2 R.sub.1.sup.1 is an ester group, R.sub.2 is a hydrogen atom or a lower alkyl group; R.sub.3 is a hydrogen atom or a lower alkyl group; and R.sub.4 is a phenyl group or a phenyl group substituted by one or two groups selected from fluorine, chlorine, OR.sub.5, NH.CO.R.sub.5, NH.CO.sub.2 R.sub.5 or CO.sub.2 R.sub.5 where R.sub.5 is a lower alkyl or benzyl group.A process for their preparation and their use in pharmaceutical compositions is also described.

    摘要翻译: 本发明提供式(II)的抗菌剂:其中R 1是CO 2 R 1是羧酸基或其盐的基团,或者是式CO 2 R 11的基团,其中R 11是这样的基团,使得CO 2 R 11 是酯基,R2是氢原子或低级烷基; R3是氢原子或低级烷基; R 4是苯基或被一个或两个选自氟,氯,OR 5,NH.CO.R 5,NH.CO 2 R 5或CO 2 R 5的基团取代的苯基,其中R 5是低级烷基或苄基。 还描述了其制备方法及其在药物组合物中的应用。

    .beta.-Lactam containing compounds, their preparation and use
    8.
    发明授权
    .beta.-Lactam containing compounds, their preparation and use 失效
    含β-内酰胺的化合物,其制备和用途

    公开(公告)号:US4446146A

    公开(公告)日:1984-05-01

    申请号:US59463

    申请日:1979-07-20

    摘要: The compounds of the formula (II): ##STR1## wherein R.sub.1 is a group such that CO.sub.2 R.sub.1 is a carboxylic acid group or a salt or ester thereof; R.sub.2 is a group of the sub-formula (a) or (b):--CR.sub.4 .dbd.C(R.sub.5) NH.CO.sub.n R.sub.6 (a)--CR.sub.7 .dbd.C(R.sub.8)R.sub.9 (b)wherein R.sub.4 is a hydrogen atom or a lower alkyl group; R.sub.5 is a hydrogen atom or a lower alkyl group; R.sub.6 is a lower alkyl, phenyl, fluorophenyl, chlorophenyl, bromophenyl or benzyl group; and n is 1 or 2; R.sub.7 is a hydrogen or a lower alkyl group; R.sub.8 is a hydrogen atom or a lower alkyl group; R.sub.9 is a hydrogen atom or a lower alkyl or phenyl group; R.sub.3 is a group of the sub-formula (c):CR.sub.10 R.sub.11 R.sub.12 (c)wherein R.sub.10 is a hydrogen atom or a hydroxyl or O.CO.R.sub.13 or O.CO.OR.sub.13 group where R.sub.13 is a lower alkyl, phenyl, benzyl, fluorobenzyl, chlorobenzyl, bromobenzyl, lower alkoxybenzyl or nitrobenzyl group; R.sub.11 is a hydrogen atom or a lower alkyl group; R.sub.12 is a hydrogen atom or a lower alkyl group; said compounds being in the form of R,S-mixture at C-5: are antibacterial agents. Their use and a process for their preparation is described.

    摘要翻译: 式(II)的化合物:其中R1是使CO 2 R 1是羧酸基团或其盐或酯的基团; R2是亚式(a)或(b)的基团:-CR4 = C(R5)NH.COnR6(a)-CR7 = C(R8)R9(b)其中R4是氢原子或低级 烷基; R5是氢原子或低级烷基; R6是低级烷基,苯基,氟苯基,氯苯基,溴苯基或苄基; n为1或2; R7是氢或低级烷基; R8是氢原子或低级烷基; R9是氢原子或低级烷基或苯基; R3是下式(c)的基团:CR10R11R12(c)其中R10是氢原子或羟基或O.CO.R13或O.CO.OR13基团,其中R13是低级烷基,苯基,苄基, 氟苄基,氯苄基,溴苄基,低级烷氧基苄基或硝基苄基; R 11是氢原子或低级烷基; R12是氢原子或低级烷基; 所述化合物是C-5的R,S-混合物的形式:是抗菌剂。 描述了它们的用途及其制备方法。

    Beta-lactam antibacterial agents
    9.
    发明授权
    Beta-lactam antibacterial agents 失效
    β-内酰胺抗菌剂

    公开(公告)号:US4431587A

    公开(公告)日:1984-02-14

    申请号:US330656

    申请日:1981-12-14

    摘要: Compounds are described of the formula (II): ##STR1## wherein R.sub.1 is a group such that CO.sub.2 R.sub.1 is an ester group; A.sub.1 is a hydrogen atom; and A.sub.2 is a group CR.sub.2 R.sub.3 R.sub.4 wherein R.sub.2 is a hydrogen atom or a hydroxyl group; R.sub.3 is a hydrogen atom or a lower alkyl group; and R.sub.4 is a hydrogen atom or a lower alkyl group, a benzyl group, a phenyl group or is joined to R.sub.3 to form part of a C.sub.5-7 carboxylic ring or is a group of the formula CH(OH)R.sub.5 or CHX wherein R.sub.5 is a hydrogen atom or lower alkyl group and X is an oxygen atom or a CR.sub.6 R.sub.7 group where R.sub.6 is a hydrogen atom or a lower alkyl, phenyl, CN, CO.sub.2 R.sub.8 where R.sub.8 is a lower alkyl, phenyl or benzyl group and R.sub.7 is a hydrogen atom or a lower alkyl group or is joined to R.sub.6 to form part of a C.sub.5-7 carbocyclic ring. These compounds have been found to possess antibacterial properties. The preparation of these compounds is described.

    摘要翻译: 化合物描述为式(II):其中R 1是使CO 2 R 1是酯基的基团; A1是氢原子; A2为基团CR2R3R4,其中R2为氢原子或羟基; R3是氢原子或低级烷基; R4为氢原子或低级烷基,苄基,苯基或与R3结合形成C5-7羧酸环的一部分,或为式CH(OH)R5或CHX的基团,其中R5 是氢原子或低级烷基,X是氧原子或其中R6是氢原子或低级烷基,苯基,CN,CO2R8的CR6R7基团,其中R8是低级烷基,苯基或苄基,R7是氢 原子或低级烷基,或者连接到R6以形成C5-7碳环的一部分。 已经发现这些化合物具有抗菌性质。 描述了这些化合物的制备。

    .beta.-Lactam containing compounds, their preparation and use
    10.
    发明授权
    .beta.-Lactam containing compounds, their preparation and use 失效
    含β-内酰胺的化合物,其制备和用途

    公开(公告)号:US4428961A

    公开(公告)日:1984-01-31

    申请号:US227765

    申请日:1981-01-23

    摘要: The present invention provides a compound of formula (I): ##STR1## wherein R.sup.1 is a group such that COOR.sup.1 is a carboxyic acid group or a salt or ester thereof;R.sup.3 is hydrogen or an organic radical;n is zero or 1;R.sup.4 and R.sup.5 are independently hydrogen or C.sub.1 -C.sub.3 alkyl;X is C.sub.1 -C.sub.6 alkylene optionally substituted by hydroxy or a carboxylic acid group or a salt or ester thereof;Y is an amino, or substituted amino, wherein the substituent is carboxylic acyl, C.sub.1 -C.sub.6 alkyl or a group .dbd.C(R.sup.14)NR.sup.15 R.sup.16 wherein R.sup.15 and or C.sub.1 -C.sub.6 alkyl and R.sup.14 is hydrogen or C.sub.1 -C.sub.6 alkyl, or a group --NR.sup.A R.sup.B wherein R.sup.A and R.sup.B are independently hydrogen or C.sub.1 -C.sub.6 alkyl.

    摘要翻译: 本发明提供式(I)化合物:其中R 1为COOR 1为羧酸基或其盐或酯的基团; R3是氢或有机基团; n为零或1; R4和R5独立地是氢或C1-C3烷基; X是任选被羟基或羧酸基团取代的C 1 -C 6亚烷基或其盐或酯; Y是氨基或取代的氨基,其中取代基是羧酰基,C 1 -C 6烷基或基团= C(R 14)NR 15 R 16,其中R 15和/或C 1 -C 6烷基和R 14是氢或C 1 -C 6烷基,或 基团-NRA RB,其中RA和RB独立地是氢或C 1 -C 6烷基。